CD19 and systemic lupus erythematosus: Sequential lymph node biopsy performed before and after CD-19 CAR T cell therapy in patients with autoimmune rheumatic diseases, including a group of patients with SLE, indicated complete B cell depletion in the lymph nodes, while T cells, macrophages, and plasma cells remained intact [129].